PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New RNA-based toolkit to regulate gene activity could advance regenerative medicine, gene therapy and biotechnology

Turning genes on and off as easily and predictably as flicking a switch could be a powerful tool in medicine and biotech. A type of technology called a riboswitch might be the key.

New RNA-based toolkit to regulate gene activity could advance regenerative medicine, gene therapy and biotechnology
2023-03-30
(Press-News.org) The Okinawa Institute of Science and Technology (OIST), in collaboration with Astellas Pharma Inc., has developed a new toolkit that uses small molecules to control the activity of a piece of synthetic RNA, and ultimately regulate gene expression. The technology, which was described in the Journal of the American Chemical Society on March 30, 2023, worked in mammalian cell cultures and in mice.

The ability to precisely control whether a gene is turned on or off is expected to lead to more efficient production of compounds that are made using animal cells, and make gene therapy, cell therapy, and regenerative medicine safer.

For genes to be expressed, cells make many RNA copies of a section of DNA. These RNA copies, called transcripts, are then used to make the protein. Scientists can take advantage of this process by introducing additional genes (either as DNA or RNA) into cells, which can then be used to make new proteins for a wide variety of applications. For example, in gene therapy, disorders caused by faulty proteins can be treated by introducing genes into body cells that code for working versions of that protein and in regenerative medicine, the expression of inserted genes could reprogram cells. Proteins with drug applications, like hormones and antibodies, can also be easily produced and collected by inserting genes into cultured cells.

However, after introducing DNA or RNA into cells, scientists need to be able to precisely control the production of the protein, so that it is made at the right time and in the right amount. This maximizes productivity and could help avoid unnecessary side effects in patients.

One method of controlling gene expression is by using ‘riboswitches’. Professor Yohei Yokobayashi, who heads OIST’s Nucleic Acid Chemistry and Engineering Unit and led this research, explained: “This type of technology involves carefully designing an RNA element called an aptamer that can specifically bind to a small molecule. This aptamer is combined with other RNA elements and inserted into the complete mRNA transcript. The mRNA introduced into the cell exists in either an on or off state, depending on whether the small molecule is present, hence the term ‘riboswitch’. This on or off state then determines if the mRNA transcript can be used to make a protein.”

Until now, however, the applications of riboswitches were very limited. The small molecules needed to make the riboswitch active or inactive required high dosages to work, either because they struggled to enter cells, or because they didn’t bind effectively to the RNA aptamer inside the cells, leading to toxic side effects.

“These aptamer sequences are designed and tested with small molecules in a test tube, so designing one that can also work in the complex environment of a cell has proven a major challenge for scientists,” said Prof. Yokobayashi.

In this study, the researchers selected several small molecules and aimed to develop RNA aptamers that would bind to them inside the cells. The result of their effort was a short RNA sequence, called AC17-4, that binds specifically to two small molecules, “ASP2905” and “ASP7967”, developed by Astellas Pharma. These molecules are drug candidates, so they can be taken up by cells easily and are not highly toxic. ASP2905 was developed for the treatment of neurological diseases and is a drug candidate compound that has undergone its Phase I clinical trial.

The researchers checked whether their riboswitches worked by incorporating them into the RNA transcripts that coded for green fluorescent protein into human-derived, cultured cells. When the two small molecules were administered to the cells, protein production from the RNA transcripts increased 10-300-fold, depending on the design of the riboswitch.

“Only a few riboswitches have shown such an increase in mammalian cells. In addition, using the compounds that are easily taken up by cells allowed the riboswitch to work at concentrations that are less than one-tenth the concentration of previously known riboswitches," said Prof Yokobayashi.

Next, with gene therapy applications in mind, the researchers at Astellas used a virus to deliver the riboswitch into mice. The riboswitch was designed to regulate the expression of human erythropoietin (hEPO). This protein is used to treat anemia associated with chronic kidney disease and is an attractive target for gene therapy in humans. When the vector was injected into mice, along with oral administration of compound ASP7967, the blood hEPO levels were 7.2 times higher compared to the control group.

Regarding the prospects of this research, Prof. Yokobayashi explained, "The riboswitch developed in this research is already practical enough for non-clinical applications, such as biopharmaceutical production and animal experiments, but further improvement is required for clinical applications, such as gene therapy. We will also continue to research other compounds and aptamers that are under development and showing promising results. In addition, we are considering applying the riboswitch in other organisms, such as plants and insects."

To achieve these goals, the research team is actively searching for new collaborative partners.

END

[Attachments] See images for this press release:
New RNA-based toolkit to regulate gene activity could advance regenerative medicine, gene therapy and biotechnology

ELSE PRESS RELEASES FROM THIS DATE:

Babies’ gut microbiome not influenced by mothers’ vaginal microbiome composition

2023-03-30
It has been a longstanding assumption that birth mode and associated exposure of newborns to their mothers’ vaginal microbiome during delivery greatly affects the development of babies’ gut microbiome. To test the scientific validity of this assumption, a team of Canadian researchers has now published a study in Frontiers in Cellular and Infection Microbiology in which they examined the effect of maternal vaginal microbiome composition on the development of infants’ stool microbiome at 10 days and three months after birth. “We show that ...

2023 Canada Gairdner Awards recognize world-renowned scientists for transformative contributions to research impacting human health

2023-03-30
The Gairdner Foundation is pleased to announce the 2023 Canada Gairdner Award laureates, recognizing some of the world’s most significant biomedical and global health research and discoveries.  “Congratulations to all the 2023 Canada Gairdner Award recipients! The ground-breaking work of this year’s laureates has resulted in innovative, globally accessible tools to fight diseases and improve our well-being. The work of two Canadian researchers – Dr. Christopher Mushquash and Dr. Gelareh Zadeh especially ...

Researchers use tiny diamonds to create intracellular sensors

Researchers use tiny diamonds to create intracellular sensors
2023-03-30
Researchers use tiny diamonds to create intracellular sensors Optically trapped nanodiamonds could be used to measure temperature, magnetic fields and other properties inside living cells VANCOUVER -- Researchers have developed a new way to study the intricate dynamics within living cells by using optically trapped nanodiamond particles as intracellular sensors. Using custom built optical tweezers, the research team trapped the particles within the cell at low power while the cell was alive. The work represents an important advancement in quantum sensing, which takes advantage of quantum mechanics to analyze changes at the atomic level.  The researchers used optical tweezers ...

New study identifies key risk factors for surgical site infection following commonly performed surgery

2023-03-30
Arlington, Va., March 30, 2023 – Findings from an analysis of more than 66,000 abdominal hysterectomies performed in New York hospitals reveal key risk factors for surgical site infections (SSIs) following these procedures, including open surgery, obesity, diabetes, gynecological cancer, and age under 45. Published today in the American Journal of Infection Control (AJIC), the data can help inform surgical and clinical decisions to reduce post-operative infections. “Improved understanding of patient-related, clinical, and surgical factors ...

Limit screen use in children under six, says psychologist

2023-03-30
“Children who are in regular contact with mobile phone screens, tablets or computers are more irritable and have worse attention, memory and concentration than those who do not use them.”  Parents should strictly ration or not allow screen time for children aged under six, according to a leading neuropsychologist in a new book.   Dr Álvaro Bilbao, Ph.D., uses current and established research to highlight how the risk of psychological and behavioral issues increases the ...

Most of world’s salt marshes likely to be underwater by 2100, study concludes

Most of world’s salt marshes likely to be underwater by 2100, study concludes
2023-03-29
By Emily Greenhalgh WOODS HOLE, MASS. -- Cape Cod’s salt marshes are as iconic as they are important. These beautiful, low-lying wetlands are some of the most biologically productive ecosystems on Earth. They play an outsized role in nitrogen cycling, act as carbon sinks, protect coastal development from storm surge, and provide critical habitats and nurseries for many fish, shellfish, and coastal birds. And, according to new research from the Marine Biological Laboratory (MBL), more than 90 percent of ...

Insilico Medicine featured in BBC-produced series on biotech breakthroughs

Insilico Medicine featured in BBC-produced series on biotech breakthroughs
2023-03-29
Insilico Medicine (“Insilico”) is featured in the new BBC StoryWorks-produced film series Nature’s Building Blocks made in conjunction with the Biotechnology Innovation Organization (BIO). Through 29 short films, the series showcases science innovations and cutting-edge technological advances that are poised to dramatically improve human life.  Insilico, a generative artificial intelligence (AI)-driven drug discovery company, is featured in a segment focused on democratizing and accelerating ...

A reconstruction of prehistoric temperatures for some of the oldest archaeological sites in North America

A reconstruction of prehistoric temperatures for some of the oldest archaeological sites in North America
2023-03-29
Scientists often look to the past for clues about how Earth’s landscapes might shift under a changing climate, and for insight into the migrations of human communities through time. A new study offers both by providing, for the first time, a reconstruction of prehistoric temperatures for some of the first known North American settlements. The study, published in Quaternary Science Reviews, uses new techniques to examine the past climate of Alaska’s Tanana Valley. With a temperature record that reaches back 14,000 years, researchers now have ...

Mimicking biological enzymes may be key to hydrogen fuel production

Mimicking biological enzymes may be key to hydrogen fuel production
2023-03-29
CHAMPAIGN, Ill. — An ancient biological enzyme known as nickel-iron hydrogenase may play a key role in producing hydrogen for a renewables-based energy economy, researchers said. Careful study of the enzyme has led chemists from the University of Illinois Urbana-Champaign to design a synthetic molecule that mimics the hydrogen gas-producing chemical reaction performed by the enzyme. The researchers reported their findings in the journal Nature Communications. Currently, industrial hydrogen is usually produced by separating hydrogen gas molecules from oxygen atoms in water using a process called ...

Ochsner Health named 2023 Gallup Exceptional Workplace Award Winner

Ochsner Health named 2023 Gallup Exceptional Workplace Award Winner
2023-03-29
NEW ORLEANS, LOUISIANA— Ochsner Health, Louisiana’s largest nonprofit, academic, multi-specialty, healthcare delivery system, has received the 2023 Gallup Exceptional Workplace Award (GEWA). This award recognizes the most engaged workplace cultures in the world. After another year of unpredictability in the workplace, Gallup found that Ochsner Health continued to put their employees’ engagement at the center of their business strategy, embedding engagement into their very culture. “Our employees are the reason for the culture of positive engagement at Ochsner Health. From physicians and providers to clinical ...

LAST 30 PRESS RELEASES:

Unlocking the mysteries of the human gut

High-quality nanodiamonds for bioimaging and quantum sensing applications

New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia

Evolution of fast-growing fish-eating herring in the Baltic Sea

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

[Press-News.org] New RNA-based toolkit to regulate gene activity could advance regenerative medicine, gene therapy and biotechnology
Turning genes on and off as easily and predictably as flicking a switch could be a powerful tool in medicine and biotech. A type of technology called a riboswitch might be the key.